Literature DB >> 20011386

Fecal incontinence.

Tracy Hull1.   

Abstract

Fecal incontinence is a devastating problem for those afflicted. It can lead to embarrassment and social isolation. Treating the problem begins with a thorough history and physical examination. Further testing (such as anal physiology testing or anal endosonography) depends on the examination and treatment plan. Conservative medical therapies (such as dietary manipulation, medication to slow the stool, and biofeedback) are usually tried first. Surgery includes sphincter repair, SECCA, artificial bowel sphincter, and stoma. New therapies continue to evolve with the intention of further improving quality of life for these afflicted patients.

Entities:  

Keywords:  Fecal incontinence; SECCA; anal physiology; artificial bowel sphincter; sphincteroplasty

Year:  2007        PMID: 20011386      PMCID: PMC2780180          DOI: 10.1055/s-2007-977490

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  35 in total

1.  Comparison of quality of life and anorectal function after artificial sphincter implantation.

Authors:  Paul-Antoine Lehur; Frank Zerbib; Michel Neunlist; Pascal Glemain; Stanislas Bruley des Varannes
Journal:  Dis Colon Rectum       Date:  2002-04       Impact factor: 4.585

2.  Long-term outcome of postanal repair in the treatment of faecal incontinence.

Authors:  Saleh M Abbas; Ian P Bissett; Mischell E Neill; Bryan R Parry
Journal:  ANZ J Surg       Date:  2005-09       Impact factor: 1.872

3.  Fecal incontinence in women with urinary incontinence and pelvic organ prolapse.

Authors:  S L Jackson; A M Weber; T L Hull; A R Mitchinson; M D Walters
Journal:  Obstet Gynecol       Date:  1997-03       Impact factor: 7.661

4.  Anal manometric parameters: predictors of outcome following anal sphincter repair?

Authors:  Susan Gearhart; Tracy Hull; Crina Floruta; Tom Schroeder; Jeff Hammel
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

5.  A prospective, randomized, controlled clinical trial of placement of the artificial bowel sphincter (Acticon Neosphincter) for the control of fecal incontinence.

Authors:  Paul E O'Brien; John B Dixon; Stewart Skinner; Cheryl Laurie; Angela Khera; David Fonda
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

6.  Biofeedback improves functional outcome after sphincteroplasty.

Authors:  L L Jensen; A C Lowry
Journal:  Dis Colon Rectum       Date:  1997-02       Impact factor: 4.585

7.  Outcome of patients with an implanted artificial anal sphincter for severe faecal incontinence. A single institution report.

Authors:  P A Lehur; P Glemain; S Bruley des Varannes; J M Buzelin; J Leborgne
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

8.  Community-based prevalence of anal incontinence.

Authors:  R Nelson; N Norton; E Cautley; S Furner
Journal:  JAMA       Date:  1995-08-16       Impact factor: 56.272

Review 9.  Innovations in fecal incontinence: sacral nerve stimulation.

Authors:  K E Matzel; U Stadelmaier; W Hohenberger
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

10.  Dynamic graciloplasty in patients born with an anorectal malformation.

Authors:  Sacha M Koch; Ozenç Uludağ; Mart-Jan Rongen; Cor G Baeten; Wim van Gemert
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

View more
  4 in total

Review 1.  Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Authors:  Julie Ann M Van Koughnett; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  Implantation of SphinKeeper(TM): a new artificial anal sphincter.

Authors:  C Ratto; L Donisi; F Litta; P Campennì; A Parello
Journal:  Tech Coloproctol       Date:  2015-12-12       Impact factor: 3.781

Review 3.  Bowel management for the treatment of pediatric fecal incontinence.

Authors:  Andrea Bischoff; Marc A Levitt; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2009-10-15       Impact factor: 1.827

4.  Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.

Authors:  L Siproudhis; W Graf; A Emmanuel; D Walker; R Ng Kwet Shing; C Pediconi; J Pilot; S Wexner; J Scholefield
Journal:  Int J Colorectal Dis       Date:  2016-04-13       Impact factor: 2.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.